Selected Publications:

Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery, Small. 17 (2021). https://doi.org/10.1002/smll.202103025.

The current landscape of nucleic acid therapeutics, Nature Nanotechnology. 16 (2021) 630–643. https://doi.org/10.1038/s41565-021-00898-0.

Scalable Production of Lipid Nanoparticles Containing Amphotericin B, Langmuir. 37 (2021) 7312–7319. https://doi.org/10.1021/acs.langmuir.1c00530.

Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles, Nanoscale. 12 (2020) 23959–23966. https://doi.org/10.1039/d0nr06816k.

Lipid nanoparticle technology for therapeutic gene regulation in the liver, Advanced Drug Delivery Reviews. 159 (2020) 344–363. https://doi.org/10.1016/j.addr.2020.06.026.

Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads, Nanoscale. 11 (2019) 9023–9031. https://doi.org/10.1039/c9nr02004g.

Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids, Journal of Controlled Release. 286 (2018) 46–54. https://doi.org/10.1016/j.jconrel.2018.07.026.

On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA, ACS Nano. 12 (2018) 4787–4795. https://doi.org/10.1021/acsnano.8b01516.